Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCAX
4626
Bicara Therapeutics
BCAX
$1.77B
| $1.9M | ﹤0.01% |
204,460
-947,671
| -82% | -$11.3M |
|
4627
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$786M
| $1.89M | ﹤0.01% |
55,700
-85,316
| -61% | -$2.9M |
|
|
DMO
4628
Western Asset Mortgage Opportunity Fund
DMO
$119M
| $1.89M | ﹤0.01% |
158,071
+22,331
| +16% | +$260K |
|
4629
iShares iBonds Dec 2029 Term Muni Bond ETF
IBMR
$464M
| $1.89M | ﹤0.01% |
74,735
+11,217
| +18% | +$280K |
|
4630
Zevra Therapeutics
ZVRA
$575M
| $1.88M | ﹤0.01% |
213,088
+1,240
| +0.6% | +$10.1K |
|
|
TIC
4631
TIC Solutions Inc
TIC
$1.6B
| $1.88M | ﹤0.01% |
169,995
+145,803
| +603% | +$1.5M |
|
4632
Northeast Community Bancorp
NECB
$380M
| $1.87M | ﹤0.01% |
80,636
+3,842
| +5% | +$87K |
|
4633
Talkspace
TALK
$873M
| $1.87M | ﹤0.01% |
673,730
+292,793
| +77% | +$862K |
|
|
CMMB
4634
Chemomab Therapeutics
CMMB
$10.5M
| $1.87M | ﹤0.01% |
403,534
+374,244
| +1,278% | +$1.85M |
|
4635
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$73.4M
| $1.87M | ﹤0.01% |
20,129
+184
| +0.9% | +$15.8K |
|
4636
First Trust Germany AlphaDEX Fund
FGM
$97M
| $1.87M | ﹤0.01% |
33,125
+28,824
| +670% | +$1.49M |
|
4637
Backblaze
BLZE
$724M
| $1.87M | ﹤0.01% |
339,419
-54,167
| -14% | -$275K |
|
4638
Nektar Therapeutics
NKTR
$2.39B
| $1.86M | ﹤0.01% |
72,139
+33,198
| +85% | +$373K |
|
4639
Pacer Trendpilot US Bond ETF
PTBD
$85.2M
| $1.86M | ﹤0.01% |
94,011
-4,678
| -5% | -$92.1K |
|
4640
Fidelity High Yield Factor ETF
FDHY
$568M
| $1.85M | ﹤0.01% |
37,928
-20,695
| -35% | -$992K |
|
|
LKFT
4641
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $1.85M | ﹤0.01% |
66,164
+40,757
| +160% | +$1.09M |
|
4642
Smith & Wesson
SWBI
$657M
| $1.85M | ﹤0.01% |
213,180
-4,851
| -2% | -$46K |
|
4643
Escalade
ESCA
$275M
| $1.84M | ﹤0.01% |
131,746
-1,350
| -1% | -$19.9K |
|
4644
NewtekOne
NEWT
$425M
| $1.84M | ﹤0.01% |
163,194
-21,549
| -12% | -$230K |
|
|
CRF
4645
Cornerstone Total Return Fund
CRF
$1.14B
| $1.84M | ﹤0.01% |
237,339
-56,171
| -19% | -$399K |
|
4646
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$349M
| $1.83M | ﹤0.01% |
47,117
+3,658
| +8% | +$131K |
|
|
CRGX
4647
DELISTED
CARGO Therapeutics
CRGX
| $1.83M | ﹤0.01% |
445,022
+162,200
| +57% | +$695K |
|
4648
Investar Holding Corp
ISTR
$415M
| $1.83M | ﹤0.01% |
94,767
+8,232
| +10% | +$152K |
|
|
UROY
4649
Uranium Royalty Corp
UROY
$408M
| $1.83M | ﹤0.01% |
732,199
-32,167
| -4% | -$65K |
|
4650
Forum Energy Technologies
FET
$593M
| $1.83M | ﹤0.01% |
93,921
-1,372
| -1% | -$22.2K |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.